Effect of Cannabis on Drivers and Screening Guideline Among Commercial Drivers
Article Sidebar
Main Article Content
Abstract
The purpose of this article is to describe the effect of cannabis on driving and to develop the guideline on cannabis screening for commercial drivers. Cannabis has a noticeable effect on driving such as lowering executive function and making drivers drive more recklessly. The method to detect cannabis exposure in the driver differs from the commonly known alcohol breathalyzer. Cannabis can be detected only from blood or urine without clinical dose response. The critical point of guideline for screening cannabis among commercial drives is to screen randomly without further notice.
Article Details
References
กรมควบคุมโรค. (2563). สถานการณ์และมาตรการความปลอดภัยทางถนน
ประกาศกระทรวงสาธารณสุข เรื่อง ชื่อ ประเภท ชนิด หรือลักษณะของผลิตภัณฑ์สมุนไพรที่ห้ามนำเข้า.
(2565, 2 มิถุนายน). ราชกิจจานุเบกษา. 139 ตอนพิเศษ 129 ง. 21
ประกาศกระทรวงสาธารณสุข เรื่อง ระบุชื่อยาเสพติดให้โทษในประเภท 5. (2565, 8 กุมภาพันธ์).
ราชกิจจานุเบกษา. 139 ตอนพิเศษ 35 ง. 8
ประกาศกรมอนามัย เรื่อง กำหนดหัวข้อวิชา การใช้กัญชา หรือกัญชง ในการทำ ประกอบ หรือปรุงอาหารที่ปลอดภัย ในการจัดการอบรมผู้ประกอบกิจการและผู้สัมผัสอาหาร. (2565, 25 สิงหาคม).
ราชกิจจานุเบกษา. 139 ตอนพิเศษ 198 ง. 32
อรรถสิทธิ์ ศรีสุบัติ และ สมชาย ธนะสิทธิชัย. (2562). กัญชากับการแพทย์แผนปัจจุบัน. วารสารกรมการแพทย์, 44(6), 5-8. แหล่งที่มา : https://he02.tci-thaijo.org/index.php/JDMS/article/view/244745
CFR 26.163 - Cutoff levels for drugs and drug metabolites. (n.d.). U.S. Government Publishing Office. Retrieved April 6, 2023, from https://www.govinfo.gov/app/details/CFR-2011-title10-vol1/CFR-2011-title10-vol1-sec26-163
FDA. (2022, January 5). Drugs of abuse home use test. U.S. Food and Drug Administration. Retrieved April 6, 2023, from https://www.fda.gov/medical-devices/drugs-abuse-tests/drugs-abuse-home-use-test
Aroonsrimorakot, S., Laiphrakpam, M., & Metadilogkul, O. (2020). Interdisciplinary Research Review Social, religious, recreational and medicinal usage of cannabis in India and Thailand. 43-50. doi:10.14456/jtir.2019.37
Asbridge, M., Hayden, J. A., & Cartwright, J. L. (2012). Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ, 344, e536. doi:10.1136/bmj.e536
Bhattacharyya, S., Crippa, J. A., Allen, P., Martin-Santos, R., Borgwardt, S., Fusar-Poli, P., . . . McGuire, P. K. (2012). Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing. Archives of General Psychiatry, 69(1), 27-36. doi:10.1001/archgenpsychiatry.2011.161
Braff, D. L., Silverton, L., Saccuzzo, D. P., & Janowsky, D. S. (1981). Impaired speed of visual information processing in marijuana intoxication. Am J Psychiatry, 138(5), 613-617. doi:10.1176/ajp.138.5.613
Chayasirisobhon, S. (2020). Mechanisms of Action and Pharmacokinetics of Cannabis. Perm J, 25, 1-3. doi:10.7812/tpp/19.200
Connors, N., Kosnett, M. J., Kulig, K., Nelson, L. S., & Stolbach, A. I. (2020). ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites. J Med Toxicol, 16(2), 240-242. doi:10.1007/s13181-019-00753-8
Couper, F. J., Pemberton, M., Jarvis, A., Hughes, M., & Logan, B. K. (2002). Prevalence of drug use in commercial tractor-trailer drivers. J Forensic Sci, 47(3), 562-567.
Dahlgren, M. K., Sagar, K. A., Smith, R. T., Lambros, A. M., Kuppe, M. K., & Gruber, S. A. (2020). Recreational cannabis use impairs driving performance in the absence of acute intoxication. Drug Alcohol Depend, 208, 107771. doi:10.1016/j.drugalcdep.2019.107771
Department of Medical Science. (2015). Standard method for analysis of narcotics in urine
(Volume I). Bangkok, Thailand: Siriraj Medical Library.
Goullé, J. P., Saussereau, E., & Lacroix, C. (2008). [Delta-9-tetrahydrocannabinol pharmacokinetics]. Ann Pharm Fr, 66(4), 232-244. doi:10.1016/j.pharma.2008.07.006
Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet, 42(4), 327-360. doi:10.2165/00003088-200342040-00003
Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chem Biodivers, 4(8), 1770-1804. doi:10.1002/cbdv.200790152
Iversen, L. (2003). Cannabis and the brain. Brain, 126(6), 1252-1270. doi:10.1093/brain/awg143
Kanchanabat, S., Arunpongpaisal, S., & Hurst, C. P. (2018). Development of the Thai Cannabis Risky Use Screening Test. Journal of Drug Issues, 49(1), 28-43. doi:10.1177/0022042618795635
MacAvoy, M. G., & Marks, D. F. (1975). Divided attention performance of cannabis users and non-users following cannabis and alcohol. Psychopharmacologia, 44(2), 147-152. doi:10.1007/BF00421001
Marcinkova, M., Straka, L., & Novomesky, F. (2019). Cannabis and alcohol in road traffic: an overview. Acta Medica Martiniana, 19(2), 71-77. doi:doi:10.2478/acm-2019-0010
Moeller, K., Kissack, J., Atayee, R., & Lee, K. (2017). Clinical Interpretation of Urine Drug Tests. Mayo Clinic Proceedings, 92. doi:10.1016/j.mayocp.2016.12.007
Moeller, K. E., Lee, K. C., & Kissack, J. C. (2008). Urine drug screening: practical guide for clinicians. Mayo Clinic Proceedings, 83(1), 66-76. doi:10.4065/83.1.66
Mura, P., Kintz, P., Dumestre, V., Raul, S., & Hauet, T. (2005). THC can be detected in brain while absent in blood. J Anal Toxicol, 29(8), 842-843. doi:10.1093/jat/29.8.842
Nahas, G. G., Frick, H. C., Lattimer, J. K., Latour, C., & Harvey, D. (2002). Pharmacokinetics of THC in brain and testis, male gametotoxicity and premature apoptosis of spermatozoa. Hum Psychopharmacol, 17(2), 103-113. doi:10.1002/hup.369
Navarro, J., Reynaud, E., & Osiurak, F. (2018). Neuroergonomics of car driving: A critical meta-analysis of neuroimaging data on the human brain behind the wheel. Neurosci Biobehav Rev, 95, 464-479. doi:10.1016/j.neubiorev.2018.10.016
Noble, M. J., Hedberg, K., & Hendrickson, R. G. (2019). Acute cannabis toxicity. Clin Toxicol (Phila), 57(8), 735-742. doi:10.1080/15563650.2018.1548708
O'Leary, D. S., Block, R. I., Turner, B. M., Koeppel, J., Magnotta, V. A., Ponto, L. B., . . . Andreasen, N. C. (2003). Marijuana alters the human cerebellar clock. Neuroreport, 14(8), 1145-1151. Retrieved from https://journals.lww.com/neuroreport/Fulltext/2003/06110/Marijuana_
alters_the_human_cerebellar_clock.9.aspx
Peleg, K., Gopher, A., Jaffe, D. H., Siman-Tov, M., & Almog, S. (2010). Comparison of blood alcohol levels with breath alcohol levels measured using the Drager 7110 MKIII breathalyzer. Injury Prevention, 16(Suppl 1), A147. doi:10.1136/ip.2010.029215.529
Ramaekers, J. G., Kauert, G., van Ruitenbeek, P., Theunissen, E. L., Schneider, E., & Moeller, M. R. (2006). High-Potency Marijuana Impairs Executive Function and Inhibitory Motor Control. Neuropsychopharmacology, 31(10), 2296-2303. doi:10.1038/sj.npp.1301068
Saitman, A., Park, H.-D., & Fitzgerald, R. L. (2014). False-positive interferences of common urine drug screen immunoassays: a review. Journal of analytical toxicology, 38(7), 387-396. doi:10.1093/jat/bku075
Schulze, H., Schumacher, M., Urmeew, R., Alvarez, J., Bernhoft, I. M., de Gier, H. d. G., . . . Zlender, B. (2012). Driving Under the Influence of Drugs, Alcohol and Medicines in Europe — findings from the DRUID project: European Monitoring Centre for Drugs.
Spiers, H. J., & Maguire, E. A. (2007). Neural substrates of driving behaviour. Neuroimage, 36(1), 245-255. doi:10.1016/j.neuroimage.2007.02.032
Surasak Im-iam, Sarannat Saensanor, and, P. S., & Sawasdichai, C. (2019). Cannabis. The Journal of Prapokklao Hospital Clinical Medical Education Center, 36(4), 7. Retrieved from https://he02.tci-thaijo.org/index.php/ppkjournal/article/view/228729/155657
Wall, M. E., Sadler, B. M., Brine, D., Taylor, H., & Perez-Reyes, M. (1983). Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther, 34(3), 352-363. doi:10.1038/clpt.1983.179
U.S. Department of Transportation. (n.d.). 49 CFR § 382 - Controlled substances and alcohol use
and testing. Legal Information Institute. Retrieved April 6, 2023, Retrieve from
